Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,615.05
(
1.67%
)
US TECH 100
23,634.00
(
1.51%
)
Dow Jones
46,454.00
(
1.92%
)
Brent Oil
95.69
(
-11.50%
)
Bitcoin
71,053.69
(
4.74%
)
News Focus
News Focus
Post# of 257271
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 131064

Monday, 11/14/2011 7:50:45 PM

Monday, November 14, 2011 7:50:45 PM

Post# of 257271

It’s getting easier to catch up as the duration of treatment in clinical trials continues to shrink.




But the challenges remain. Safety, tolerability, potency/dosing, efficacy, and resistance profile. It's interesting how many HCV developers are working on purine nukes while the most successful nucleotide to date (PSI-7977) is pyrimidine based. Do you know of any other developers working on a pyrimidine?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today